Literature DB >> 25218765

Dixon imaging-based partial volume correction improves quantification of choline detected by breast 3D-MRSI.

Lenka Minarikova1, Stephan Gruber, Wolfgang Bogner, Katja Pinker-Domenig, Pascal A T Baltzer, Thomas H Helbich, Siegfried Trattnig, Marek Chmelik.   

Abstract

OBJECTIVES: Our aim was to develop a partial volume (PV) correction method of choline (Cho) signals detected by breast 3D-magnetic resonance spectroscopic imaging (3D-MRSI), using information from water/fat-Dixon MRI.
METHODS: Following institutional review board approval, five breast cancer patients were measured at 3 T. 3D-MRSI (1 cm(3) resolution, duration ~11 min) and Dixon MRI (1 mm(3), ~2 min) were measured in vivo and in phantoms. Glandular/lesion tissue was segmented from water/fat-Dixon MRI and transformed to match the resolution of 3D-MRSI. The resulting PV values were used to correct Cho signals. Our method was validated on a two-compartment phantom (choline/water and oil). PV values were correlated with the spectroscopic water signal. Cho signal variability, caused by partial-water/fat content, was tested in 3D-MRSI voxels located in/near malignant lesions.
RESULTS: Phantom measurements showed good correlation (r = 0.99) with quantified 3D-MRSI water signals, and better homogeneity after correction. The dependence of the quantified Cho signal on the water/fat voxel composition was significantly (p < 0.05) reduced using Dixon MRI-based PV correction, compared to the original uncorrected data (1.60-fold to 3.12-fold) in patients.
CONCLUSIONS: The proposed method allows quantification of the Cho signal in glandular/lesion tissue independent of water/fat composition in breast 3D-MRSI. This can improve the reproducibility of breast 3D-MRSI, particularly important for therapy monitoring.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25218765     DOI: 10.1007/s00330-014-3425-1

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  24 in total

1.  Assessment of therapeutic response of locally advanced breast cancer (LABC) patients undergoing neoadjuvant chemotherapy (NACT) monitored using sequential magnetic resonance spectroscopic imaging (MRSI).

Authors:  Karikanni Kalathil A Danishad; Uma Sharma; Rani G Sah; Vurthaluru Seenu; Rajinder Parshad; Naranamangalam R Jagannathan
Journal:  NMR Biomed       Date:  2010-04       Impact factor: 4.044

2.  Proton MR spectroscopy for monitoring early treatment response of breast cancer to neo-adjuvant chemotherapy.

Authors:  H-M Baek; J-H Chen; O Nalcioglu; M-Y Su
Journal:  Ann Oncol       Date:  2008-03-27       Impact factor: 32.976

3.  Use of tissue water as a concentration reference for proton spectroscopic imaging.

Authors:  Charles Gasparovic; Tao Song; Deidre Devier; H Jeremy Bockholt; Arvind Caprihan; Paul G Mullins; Stefan Posse; Rex E Jung; Leslie A Morrison
Journal:  Magn Reson Med       Date:  2006-06       Impact factor: 4.668

4.  Improved diagnostic accuracy with multiparametric magnetic resonance imaging of the breast using dynamic contrast-enhanced magnetic resonance imaging, diffusion-weighted imaging, and 3-dimensional proton magnetic resonance spectroscopic imaging.

Authors:  Katja Pinker; Wolfgang Bogner; Pascal Baltzer; Stephan Gruber; Hubert Bickel; Benedikt Brueck; Siegfried Trattnig; Michael Weber; Peter Dubsky; Zsuzsanna Bago-Horvath; Rupert Bartsch; Thomas H Helbich
Journal:  Invest Radiol       Date:  2014-06       Impact factor: 6.016

5.  Signal modulation in (1)H magnetic resonance spectroscopy using contrast agents: proton relaxivities of choline, creatine, and N-acetylaspartate.

Authors:  P S Murphy; M O Leach; I J Rowland
Journal:  Magn Reson Med       Date:  1999-12       Impact factor: 4.668

6.  Characterization of neoplastic and normal human breast tissues with in vivo (1)H MR spectroscopy.

Authors:  K A Kvistad; I J Bakken; I S Gribbestad; B Ehrnholm; S Lundgren; H E Fjøsne; O Haraldseth
Journal:  J Magn Reson Imaging       Date:  1999-08       Impact factor: 4.813

7.  Effect of contrast agent on the results of in vivo ¹H MRS of breast tumors - is it clinically significant?

Authors:  Pascal A T Baltzer; Alexander Gussew; Matthias Dietzel; Reinhard Rzanny; Mieczyslaw Gajda; Oumar Camara; Jürgen R Reichenbach; Werner A Kaiser
Journal:  NMR Biomed       Date:  2011-05-09       Impact factor: 4.044

8.  Three-dimensional proton MR spectroscopic imaging at 3 T for the differentiation of benign and malignant breast lesions.

Authors:  Stephan Gruber; Bogumil-Krystian Debski; Katja Pinker; Marek Chmelik; Guenther Grabner; Thomas Helbich; Siegfried Trattnig; Wolfgang Bogner
Journal:  Radiology       Date:  2011-10-13       Impact factor: 11.105

9.  Detection of choline signal in human breast lesions with chemical-shift imaging.

Authors:  Hyeon-Man Baek; Jeon-Hor Chen; Hon J Yu; Rita Mehta; Orhan Nalcioglu; Min-Ying Su
Journal:  J Magn Reson Imaging       Date:  2008-05       Impact factor: 4.813

Review 10.  Breast lesions: diagnosis by using proton MR spectroscopy at 1.5 and 3.0 T--systematic review and meta-analysis.

Authors:  Pascal A T Baltzer; Matthias Dietzel
Journal:  Radiology       Date:  2013-03-06       Impact factor: 11.105

View more
  1 in total

Review 1.  Proton MR spectroscopy in the breast: Technical innovations and clinical applications.

Authors:  Reza Fardanesh; Maria Adele Marino; Daly Avendano; Doris Leithner; Katja Pinker; Sunitha B Thakur
Journal:  J Magn Reson Imaging       Date:  2019-03-07       Impact factor: 4.813

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.